LONDON, March 22 -- A series of health projects, which aim to transform outcomes for patients through new technology, have received funding from the Biomedical Catalyst program, the UK Research and Innovation (UKRI) announced on Friday.
The Biomedical Catalyst program is jointly run by Innovate UK and the Medical Research Council, both of which are parts of UKRI.
Nine early stage projects have received total funding of almost 7.5 million pounds (about 9.9 million U.S. dollars). These include a new software which enables radiologists to diagnose breast cancer more effectively. Meanwhile, 15 feasibility projects have received a total funding of just over 2 million pounds (around 2.6 million U.S. dollars).
In the latest round of awards, the MRC also committed a significant amount of funding to other medical projects.
The success of the Catalyst's funding schemes shows the value of dedicated support in the development of therapies, diagnostics and devices that will benefit both patients and Britain's economy, said Louise Jones, head of translational research at the MRC.
欲速则不达
体坛英语资讯:BWF announces suspension of badminton tournaments due to escalation of COVID-19 oubreak
流行音乐之我见
国际英语资讯:Algeria president warns to tighten measures after resurgence of COVID-19 cases
中国外文局审定新冠肺炎相关词汇特刊
暗香
体坛英语资讯:Uganda rout Tanzania in 2020 FIFA U-17 Womens World Cup qualifier
新苑社区法院宿舍环境报告
国际英语资讯:Ecuadorian president urges workers, employers to come to agreements to avoid layoffs amid pa
国内英语资讯:Take a cue from Chinas policies to eradicate poverty:experts